Drug · DIN 02528541
WEGOVY
DISPENSES 2.4 MG DOSES. MULTIDOSE PREFILLED PEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 22, 2024; first marketed April 22, 2024.
- Drug Identification Number (DIN)
- 02528541
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Semaglutide A10BJ06
- Class
- Human
- Record last updated
- October 5, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SEMAGLUTIDE | 9.6 MG | 3 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 30, 2022: NOC 28508Supplement to a New Drug Submission (SNDS) · New presentation
Other DINs named WEGOVY
- DIN 02528509 · Marketed
- DIN 02528517 · Marketed
- DIN 02528525 · Marketed
- DIN 02528533 · Marketed
- DIN 02552698 · Marketed
- DIN 02522551 · Approved
- DIN 02522578 · Approved
- DIN 02522586 · Approved
- DIN 02522594 · Approved
- DIN 02522608 · Approved